The moment a clinician suggests participating in a clinical trial, many senior patients may worry that they won’t be able to afford the costs associated with the trial. This financial concern is not misplaced. According to data from the Medicare Rights Center, 66 percent of Americans in 2026 are worried about rising healthcare expenses. Adults between 50 and 64 carry the highest medical debt in the country, disproportionately impacting Black people and individuals living in rural communities.
However, while healthcare costs are a significant concern, Medicare often covers important services such as clinical research trials.
While it is true that Medicare covers clinical trial costs, not all aspects of the trial are covered. Social Security Act § 1862(m), 42 U.S.C. § 1395y(m) (2024), states that Medicare generally pays for routine costs associated with qualifying clinical trials.
The Centers for Medicare and Medicaid Services (CMS) is the U.S. federal agency that determines whether or not Medicare will cover routine costs for clinical trials. CMS clinical trial coverage applies to those enrolled in Medicare Parts A and B, or both. Patients may participate in a research trial without losing access to their standard care. For a clinical trial to qualify, it must meet specific federal criteria, and if it does, Medicare will treat a patient’s participation the same as their standard treatment.
Routine patient care in a clinical trial refers to the medical services and treatments that would normally be covered even if the patient were not participating in the study. These are the standard parts of care needed to monitor, treat, and support a patient’s health during the trial.
These include:
“If there exists a benefit category and it’s not statutorily excluded, and there’s not a national coverage determination or decision on that, those are things that are provided in either the experimental or the control on the clinical trial,” explained Mary Sue Gardner, RN in charge of provider outreach and education at Wisconsin Physicians Service Insurance Corporation (WPS) “All of those are included except the actual investigational item or service unless its otherwise covered outside the clinical trial,” Gardner elaborated during a WPS online webinar.
Bottom line, if a service would be covered under Medicare outside of a clinical trial, it is generally covered during participation in a qualifying trial as well. This helps ensure patients are not financially disadvantaged for choosing to enroll in an approved research study.
RELATED: How Much Do Clinical Trials Pay? What Participants Should Know
Typically, the clinical trial sponsor will cover the costs of the experimental medical device or drug that is being studied; Medicare does not cover the product. It also does not pay for data collection or research services. Again, those are often covered by the trial sponsor.
If any care beyond what’s normally covered within the trial, or services obtained from non-approved providers, Medicare will not cover those either. These gaps typically mean that while much of the care is covered, some trial-related expenses might fall outside of Medicare’s scope.
First and foremost, a qualifying clinical trial must aim to improve health outcomes and meet established scientific and ethical standards recognized by federal agencies. Generally, trials funded by government agencies are often automatically qualified.
Studies that only examine side effects, how a drug moves through the body, how a disease works in a lab setting, or studies that aren’t properly approved, overseen, or officially registered, do not qualify. Medicare requires that a trial evaluate a product or treatment within its benefit categories and that it not be otherwise excluded from coverage.
While Medicare covers routine care, patients may still incur out-of-pocket costs such as deductibles, copayments, and coinsurance. This is why it is important to clarify costs and financial responsibilities before participating in a clinical trial. Supplemental insurance or Medicaid may offset some of these costs, but more often than not, the participant will experience some out-of-pocket costs.
Medicare coverage for clinical trials can make a real difference in who gets access to cutting-edge care. For many underserved communities, including Black patients who face higher rates of chronic diseases like diabetes, heart disease, and cancer, cost can be a barrier to participation.
When routine care in trials is covered, it lowers financial risk and makes enrollment more realistic for people who might otherwise be excluded. This matters because these groups have historically been underrepresented in research, leading to gaps in how treatments work across populations. Expanding coverage improves equity, increases representation, and ensures that medical advances benefit a broader, more diverse population.
Taking a few simple steps to confirm Medicare coverage before enrolling in a clinical trial can help prevent unexpected medical bills. The clearest answers usually come from a combination of the trial team, your healthcare provider, and Medicare.
Here’s a checklist that can guide you through the process:
Before agreeing to join a clinical trial, ask the following questions to help you make an informed decision about participation:
RELATED: 15 Questions to Ask About Clinical Trials
It’s also important to ask about the logistics of participation, including how many times you’re expected to come into the office, the time commitment, the duration of the trial, risks, and any other concerns you may have, so you have all the information you need to make an informed decision.
As potential trial participants, patients are entitled to the right of informed consent: the process by which they are given clear information about a medical treatment or clinical trial, including its risks and benefits, so that they may make a voluntary decision with all available information. Transparency about costs is also required for participation in clinical research. Under federal informed consent regulations, clinical trials must clearly explain any expected additional costs participants may incur, including what might be billed to their insurance or paid out of pocket. This requirement, outlined in 21 CFR 50.25(b)(3), ensures that individuals are fully informed of potential financial risks before agreeing to take part in a study.
By subscribing, you consent to receive emails from BlackDoctor.com. You may unsubscribe at any time. Privacy Policy & Terms of Service.
